Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sufentanil transdermal - tesa Labtec

X
Drug Profile

Sufentanil transdermal - tesa Labtec

Alternative Names: Sufentanil TDS

Latest Information Update: 06 Nov 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Labtec
  • Developer hameln rds; tesa Labtec
  • Class Amides; General anaesthetics; Opioid analgesics; Piperidines; Small molecules; Thiophenes
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Cancer pain; Pain

Most Recent Events

  • 08 Mar 2017 Discontinued - Phase-I for Pain in Germany before March 2017 (Transdermal)
  • 08 Mar 2017 Discontinued - Phase-II for Cancer pain in Slovakia before March 2017 (Transdermal)
  • 27 Jul 2015 No recent reports on development identified - Phase-I for Pain in Germany (Transdermal)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top